Gene Therapy Market is expected to reach US$ 51.22 billion by 2031 | Novartis AG, Gilead Sciences, Jazz Pharmaceuticals, Orchard Therapeutics

Global Gene Therapy Market reached US$ 4.67 billion in 2023 and is expected to reach US$ 51.22 billion by 2031, growing at a CAGR of 31.89% during the forecast period 2024-2031

Gene Therapy Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/gene-therapy-market?sg

Gene therapy is an advanced medical treatment that modifies or replaces genes to treat or prevent diseases. This approach involves adding functional genes, repairing faulty ones, or deactivating harmful ones, with the goal of addressing genetic disorders at their root cause.

In October 2021, the National Institutes of Health (NIH), the Food and Drug Administration (FDA), ten pharmaceutical companies, and five non-profit organizations collaborated to accelerate gene therapy development for the 30 million Americans affected by rare diseases. Despite approximately 7,000 rare diseases, only two inherited disorders currently have FDA-approved gene therapies.

The global gene therapy market is expanding due to increased government funding for research, a growing prevalence of chronic diseases such as cancer and rare genetic conditions, and rising cases of autoimmune disorders.

List of the Key Players in the Gene Therapy Market: Novartis AG, Gilead Sciences, Jazz Pharmaceuticals, Orchard Therapeutics, Bristol-Myers Squibb, Amgen, SiBiono Genentech, Shanghai Sunway Biotech Co, Adapt immune Therapeutics and Adverum Biotechnologies.

Industry Development:

In Feb 2023 Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration. The program leverages Charles River's established plasmid platform, eXpDN and decades of experience at the Company's plasmid DNA manufacturing center of excellence to support the first gene therapy platform targeting renal diseases, which affect approximately 840 million people, or roughly 10% of the global population.

In May 2023 Forge Biologics and LabCorp partner for gene therapies development. The alliance will aim to shorten trial timeframes and eliminate analytical development restrictions, as well as solve any regulatory problems connected to manufacturing and development procedures. ​

Growth Forecast Projected:

The Global Gene Therapy Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Gene Therapy Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/gene-therapy-market?sg

Segment Covered in the Gene Therapy Market:

By Therapy Type (Somatic Gene Therapy, Germline Therapy)

By Drug Class (Cardiology, Neurology, Oncology, Infectious Diseases, Inherited Diseases, Others)

By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa)

Regional Analysis for Gene Therapy Market:

The regional analysis of the Gene Therapy Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

View Our Full Report: https://www.datamintelligence.com/research-report/gene-therapy-market?sg

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Gene Therapy market?

➠ Who are the leading manufacturers in the global Gene Therapy industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Gene Therapy industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Gene Therapy market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports:

Gene Therapy For Rare Disease Market - https://www.datamintelligence.com/research-report/gene-therapy-for-rare-disease-market?sg

Cell and Gene Therapy Market - https://www.datamintelligence.com/research-report/cell-and-gene-therapy-market?sg

Cell and Gene Therapy Manufacturing Services Market - https://www.datamintelligence.com/research-report/cell-and-gene-therapy-manufacturing-services-market?sg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.